Arysta Life Sciences

UPL completes Arysta acquisition

Generic agrochemical manufacturer UPL has completed its acquisition of Arysta LifeScience which creates a “new UPL” with combined earnings of some $1 billion on revenues of $5 billion. The Indian multinational agreed to buy US-based Arysta from Platform Specialty...

read more

UK country head for new UPL

Following UPL’s acquisition of Arysta Life Science, Alan du Rieu becomes country head for UPL UK & Ireland. He was previously Arysta’s commercial director for north west Europe. Mr du Rieu has more than 25 years’ experience in technical and commercial agriculture. He...

read more